SCHEMBL23360613

SCHEMBL23360613

CN(c1ccc2ccccc2n1)C1CCN(C(=O)O)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NCF1 P14598 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.42
ALDH1A1 P00352 2/20 0.42
FAAH O00519 1/20 0.42
MITF O75030 1/20 0.42
PKM P14618 1/20 0.42
TSHR P16473 2/20 0.42
POLB P06746 2/20 0.42
MAPK1 P28482 1/20 0.42
PDE10A Q9Y233 1/20 0.39
SMO Q99835 4/20 0.39
KDM1A O60341 2/20 0.38
MAOA P21397 2/20 0.38
MAOB P27338 2/20 0.38
KDM4E B2RXH2 1/20 0.38
NMT1 P30419 1/20 0.38
MGAM O43451 1/20 0.38
KCNH2 Q12809 2/20 0.38
EPHX1 P07099 1/20 0.38
EPHX2 P34913 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23360433 0.93 NCF1 (0.43) NCF1SMN1; SMN2ALDH1A1FAAHMITF
SCHEMBL23360434 0.93 NCF1 (0.43) NCF1SMN1; SMN2ALDH1A1FAAHMITF
SCHEMBL29863135 0.83 GPR119 (0.48) PDE10AMEN1KMT2A
SCHEMBL23360071 0.83 GPR119 (0.48) PDE10AMEN1KMT2A
SCHEMBL25774139 0.82 NCF1 (0.61) NCF1SMN1; SMN2ALDH1A1MITFPKM
SCHEMBL28834341 0.79 USP30 (0.53) PDE10AMEN1KMT2A
SCHEMBL28834338 0.79 USP30 (0.53) PDE10AMEN1KMT2A
SCHEMBL4118965 0.77 JAK2 (0.46) SMN1; SMN2ALDH1A1KDM4EL3MBTL3
SCHEMBL2896994 0.76 L3MBTL3 (0.46) KDM1AMAOAMAOBKCNH2L3MBTL3
Hydrochloric Acid SCHEMBL29862559 0.74 NCF1 (0.51) NCF1SMN1; SMN2ALDH1A1MITFPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114867719-B Pyrrolidine and piperidine compounds 柳韩洋行 2024-06-25 CN disclosed
US-11655235-B2 Pyrrolidine and piperidine compounds YUHAN CORPORATION (KR) 2023-05-23 US disclosed
EP-4055014-A1 PYRROLIDINE AND PIPERIDINE COMPOUNDS Yuhan Corporation (KR) 2022-09-14 EP disclosed
CN-114867719-A Pyrrolidine and piperidine compounds 柳韩洋行 2022-08-05 CN disclosed
US-20210147386-A1 PYRROLIDINE AND PIPERIDINE COMPOUNDS YUHAN CORPORATION (KR) 2021-05-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11655235-B2 Pyrrolidine and piperidine compounds FAP, APC, VHL NCF1 3946/4885SMN1; SMN2 387/4885ALDH1A1 439/4885
US-20210147386-A1 PYRROLIDINE AND PIPERIDINE COMPOUNDS FAP, APC, VHL NCF1 3946/4885SMN1; SMN2 387/4885ALDH1A1 439/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.